02617.HK 财务： TransThera Sciences (Nanjing), Inc. AI 分析

Q: 技术分析指标如何适用于 02617.HK？

根据技术分析，TransThera Sciences (Nanjing), Inc. 的综合信号为 Sell。TransThera Sciences (Nanjing), Inc. 有 2 个买入信号，0 个中性信号和 5 个卖出信号。

Q: 02617.HK 的斐波那契回调水平是多少？

TransThera Sciences (Nanjing), Inc. 的斐波那契回调水平是 高于0%水平。

Q: TransThera Sciences (Nanjing), Inc. 的 RSI 是多少？

TransThera Sciences (Nanjing), Inc. 的 RSI 目前为 15.79，表明处于 超卖 状态

Q: TransThera Sciences (Nanjing), Inc. 接下来 12 个月的价格是多少？

TransThera Sciences (Nanjing), Inc. 02617.HK 接下来 12 个月的价格预计为 $0。

Q: TransThera Sciences (Nanjing), Inc. 预计会涨到多高？

据华尔街分析师称，TransThera Sciences (Nanjing), Inc. 预计将达到 $0 的高预测值。

主页

股票

02617.HK

预测

TRANSTHERA-B (02617.HK)

TransThera Sciences (Nanjing), Inc.

HK$93.3

-2.3%

$-2.2

盘中： Jan 19, 15:01:48 HKT

关键数据

前收盘价

$95.5

开盘价

$95.5

当日区间

$93 - $97.95

52周范围

$20.2 - $679.5

交易量

461.0K

平均成交量

1.7M

每股收益（TTM）

-0.66

股息收益率

市值

$28.1B

什么是 TRANSTHERA-B？

TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. The company is headquartered in Nanjing, Jiangsu and currently employs 121 full-time employees. The company went IPO on 2025-06-23. The firm's core product Tinengotinib is a registrational clinical stage, internally discovered and developed, MTK inhibitor indicated for certain relapsed or refractory, drug-resistant solid tumors. The firm's oncology pipeline includes TT-00973 (against AXL), TT-01488 (for hematologic malignancies), TT-01688 (for inflammatory diseases) and TT-00920 (for chronic heart failure). The products are capable of being efficacious in a broad range of cancer types (including prostate cancer, HCC, breast cancer, and BTC). The company is also applied to cure hepatocellular carcinoma, breast cancer, biliary tract cancer and Pan-FGFR solid tumor.

功能特性

交易策略

资源

市场

02617.HK 股价预测摘要

02617.HK stock price ended at $95.5 on 星期五, after rising 0.26%

On the latest trading day Jan 16, 2026, the stock price of 02617.HK rose by 0.26%, climbing from $97.55 to $95.50. During the session, the stock saw a volatility of 11.02%, with prices oscillating between a daily low of $93.50 and a high of $103.80. Notably, trading volume dropped by 1.4M shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.5M shares were traded, equating to a market value of approximately $28.8B.

02617.HK 技术面信号

技术面信号摘要

购买信号 2

中性信号 0

卖出信号 5

Strong Sell

Sell

Neutral

Buy

Strong Buy

02617.HK目前显示2个买入信号和5个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为-4.6%。总体而言，技术指标显示中期前景为Sell。

02617.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 02617.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 02617.HK？



02617.HK 的斐波那契回调水平是多少？



TransThera Sciences (Nanjing), Inc. 的 RSI 是多少？



TransThera Sciences (Nanjing), Inc. 接下来 12 个月的价格是多少？



TransThera Sciences (Nanjing), Inc. 预计会涨到多高？



TransThera Sciences (Nanjing), Inc.（02617.HK）价格

02617.HK 股价走势图